Consumer demand, scientific innovation, and technology-led care are not new forces in health industries M&A, but in 2026, they have become more important than ever. Demand is shifting the growth model from premium-priced therapies for narrower populations toward broader-access treatments. Prevention and consumer-funded care are also becoming larger investable growth pools. And data and AI are rapidly changing how healthcare companies discover and deliver care. Investors are responding with greater selectivity and conviction, as shown by the uptick in megadeals (transactions valued at more than $5bn) in early 2026.
Read the full article: PwC 2026 Mid-Year Outlook: Global M&A Trends in Health Industries //
Source: https://www.pwc.com/gx/en/services/deals/trends/health-industries.html